Drug formulation and Chemistry, Manufacturing, and Controls (CMC)
From “Idea to patient” (Idé till patient) is a podcast from SwedenBIO and the Center for Translational Research (CTR), hosted by Jenny Högblad, that aims to discuss drug development from idea to clinical studies. In this podcast, Jenny and her guests discuss topics such as the importance of having a target product profile (TPP), performing early toxicology studies, and choosing the right drug formulation for use in clinical studies.
In this episode, Jenny is joined by Agneta Larhed (RegSmart Life Science) and Fredrik Lehmann (Oncopeptides) to discuss strategies for formulation and CMC, and why it’s important to get it right from the start.
Listen to this episode (in Swedish) on Spotify, Apple Podcasts, or directly in your web browser.
Is your investigational product ready for clinical development? Learn how SCRO’s services can support you.
